Cell Source, Inc.

Cell Source, Inc.verified

CLCS

Price:

$0.82

Market Cap:

$36.93M

Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based therapies centered on regulating immune tolerance. The company's flagship innovation is its Veto Cell immune system management technology, an advanced immune tolerance platform capable of selectively suppressing specific immune responses. This Veto Cell technology finds application in numerous areas, including enhancing the acceptance of stem cell transplants for conditions like lymphoma, leukemia, and multiple myeloma. Furthermore, it is utilized in treating end-stage kidney disease, various other non-malignant organ diseases, and a spectrum of both cancerous and non-malignant illnesses. Founded in 2012, Cell Source,...[Read more]

Industry

Biotechnology

IPO Date

2014-05-01

Stock Exchange

OTC

Ticker

CLCS

The PE Ratio as of June 2026 (TTM) for Cell Source, Inc. (CLCS) is -5.86

According to Cell Source, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -5.86. This represents a change of 92.43% compared to the average of -3.05 of the last 4 quarters.

Cell Source, Inc. (CLCS) Historical PE Ratio (quarterly & annually)

How has CLCS PE Ratio performed in the past?

The mean historical PE Ratio of Cell Source, Inc. over the last ten years is -7.63. The current -5.86 PE Ratio has changed 7.58% with respect to the historical average. Over the past ten years (40 quarters), CLCS's PE Ratio was at its highest in in the December 2016 quarter at 2.17. The PE Ratio was at its lowest in in the June 2018 quarter at -15.93.

Quarterly (TTM)
Annual

Average

-7.63

Median

-6.77

Minimum

-14.38

Maximum

-2.17

Cell Source, Inc. (CLCS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Cell Source, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 378.03%

Maximum Annual PE Ratio = -2.17

Minimum Annual Increase = -82.17%

Minimum Annual PE Ratio = -14.38

Quarterly (TTM)
Annual
YearPE RatioChange
2024-3.0713.83%
2023-2.70-52.90%
2022-5.73-12.88%
2021-6.58-48.47%
2020-12.7683.28%
2019-6.96-28.46%
2018-9.73348.34%
2017-2.17-82.17%
2016-12.18-15.32%
2015-14.38378.03%

Cell Source, Inc. (CLCS) Average PE Ratio

How has CLCS PE Ratio performed in the past?

The current PE Ratio of Cell Source, Inc. (CLCS) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-3.83

5-year avg

-6.17

10-year avg

-7.63

Cell Source, Inc. (CLCS) PE Ratio vs. Peers

How is CLCS’s PE Ratio compared to its peers?

Cell Source, Inc.’s PE Ratio is less than Zenith Capital Corp. (-1.51), less than Synairgen plc (-0.23), less than Quest PharmaTech Inc. (1.49), less than Gemina Laboratories Ltd. (-1.57), less than Propanc Biopharma, Inc. (-0.11), less than AccuStem Sciences Limited (-0.00), greater than Telescope Innovations Corp. (-21.55), less than Hemostemix Inc. (-2.33), less than Sirona Biochem Corp. (-0.71), less than Hadasit Bio-Holdings Ltd (-2.67),

Build a custom stock screener for Cell Source, Inc. (CLCS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cell Source, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cell Source, Inc. (CLCS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cell Source, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Cell Source, Inc.'s PE Ratio?

How is the PE Ratio calculated for Cell Source, Inc. (CLCS)?

What is the highest PE Ratio for Cell Source, Inc. (CLCS)?

What is the 3-year average PE Ratio for Cell Source, Inc. (CLCS)?

What is the 5-year average PE Ratio for Cell Source, Inc. (CLCS)?

How does the current PE Ratio for Cell Source, Inc. (CLCS) compare to its historical average?